Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis.
作者信息
Molina-Molina Maria
机构信息
1Respiratory DepartmentBellvitge University Hospital-Bellvitge Institute for Biomedical ResearchBarcelona, Spainand.
2CIBER of Respiratory DiseasesMadrid, Spain.
出版信息
Am J Respir Crit Care Med. 2019 Aug 1;200(3):274-275. doi: 10.1164/rccm.201812-2330ED.
Abstract
摘要
相似文献
1
Telomere Shortening Is behind the Harm of Immunosuppressive Therapy in Idiopathic Pulmonary Fibrosis.端粒缩短是特发性肺纤维化中免疫抑制治疗危害的背后原因。
Am J Respir Crit Care Med. 2019 Aug 1;200(3):274-275. doi: 10.1164/rccm.201812-2330ED.
2
Pulmonary fibrosis: Genetic analysis of telomere-related genes, telomere length measurement-or both?肺纤维化：端粒相关基因的遗传分析、端粒长度测量——还是两者皆有？
Respirology. 2019 Feb;24(2):97-98. doi: 10.1111/resp.13456. Epub 2018 Dec 17.
3
Telomere Shortening in Idiopathic Pulmonary Fibrosis.
Arch Bronconeumol (Engl Ed). 2018 Jan;54(1):3-4. doi: 10.1016/j.arbres.2017.07.026. Epub 2017 Sep 14.
4
[A concise review of telomere and telomerase-related genetic markers in fibrotic lung diseases].[纤维化性肺疾病中端粒和端粒酶相关遗传标志物的简要综述]
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi. 2020 Dec 20;38(12):952-956. doi: 10.3760/cma.j.cn121094-20200305-00104.
5
Telomerase gene mutations and telomere length shortening in patients with idiopathic pulmonary fibrosis in a Chinese population.中国人群特发性肺纤维化患者的端粒酶基因突变与端粒长度缩短
Respirology. 2015 Jan;20(1):122-8. doi: 10.1111/resp.12422. Epub 2014 Oct 23.
6
A clinical short-cut to identifying short telomeres in idiopathic pulmonary fibrosis?一种识别特发性肺纤维化中短端粒的临床捷径？
Respirology. 2022 Nov;27(11):916-917. doi: 10.1111/resp.14355. Epub 2022 Aug 28.
7
Clinical implications of telomere dysfunction in lung fibrosis.端粒功能障碍在肺纤维化中的临床意义。
Curr Opin Pulm Med. 2018 Sep;24(5):440-444. doi: 10.1097/MCP.0000000000000506.
8
From organ to cell: Multi-level telomere length assessment in patients with idiopathic pulmonary fibrosis.从器官到细胞：特发性肺纤维化患者的端粒长度多水平评估。
PLoS One. 2020 Jan 7;15(1):e0226785. doi: 10.1371/journal.pone.0226785. eCollection 2020.
9
Telomerase and idiopathic pulmonary fibrosis.端粒酶与特发性肺纤维化。
Mutat Res. 2012 Feb 1;730(1-2):52-8. doi: 10.1016/j.mrfmmm.2011.10.013. Epub 2011 Nov 4.
10
Pulmonary Fibrosis and a TERT Founder Mutation With a Latency Period of 300 Years.肺纤维化与 TERT 基因突变：潜伏期长达 300 年
Chest. 2020 Aug;158(2):612-619. doi: 10.1016/j.chest.2020.03.069. Epub 2020 Apr 19.
引用本文的文献
1
Common Molecular Pathways Between Post-COVID19 Syndrome and Lung Fibrosis: A Scoping Review.新冠后综合征与肺纤维化之间的常见分子途径：一项范围综述
Front Pharmacol. 2022 Mar 4;13:748931. doi: 10.3389/fphar.2022.748931. eCollection 2022.
2
Lung Transplant Improves Survival and Quality of Life Regardless of Telomere Dysfunction.无论端粒功能障碍如何，肺移植都能提高生存率和生活质量。
Front Med (Lausanne). 2021 Jul 30;8:695919. doi: 10.3389/fmed.2021.695919. eCollection 2021.
3
Progression in the Management of Non-Idiopathic Pulmonary Fibrosis Interstitial Lung Diseases, Where Are We Now and Where We Would Like to Be.非特发性肺纤维化间质性肺疾病的管理进展：我们目前的状况及未来期望达到的目标
J Clin Med. 2021 Mar 23;10(6):1330. doi: 10.3390/jcm10061330.
本文引用的文献
1
Telomere Length and Use of Immunosuppressive Medications in Idiopathic Pulmonary Fibrosis.特发性肺纤维化中端粒长度与免疫抑制药物的使用。
Am J Respir Crit Care Med. 2019 Aug 1;200(3):336-347. doi: 10.1164/rccm.201809-1646OC.
2
Predictive factors and prognostic effect of telomere shortening in pulmonary fibrosis.肺纤维化中端粒缩短的预测因素和预后影响。
Respirology. 2019 Feb;24(2):146-153. doi: 10.1111/resp.13423. Epub 2018 Oct 15.
3
Impaired Cytomegalovirus Immunity in Idiopathic Pulmonary Fibrosis Lung Transplant Recipients with Short Telomeres.特发性肺纤维化肺移植受者短端粒导致巨细胞病毒免疫受损。
Am J Respir Crit Care Med. 2019 Feb 1;199(3):362-376. doi: 10.1164/rccm.201805-0825OC.
4
Clinical implications of telomere dysfunction in lung fibrosis.端粒功能障碍在肺纤维化中的临床意义。
Curr Opin Pulm Med. 2018 Sep;24(5):440-444. doi: 10.1097/MCP.0000000000000506.
5
Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.端粒酶基因中蛋白改变变异的分析及其与特发性肺纤维化患者 MUC5B 常见变异体状态的关系：候选基因测序研究。
Lancet Respir Med. 2018 Aug;6(8):603-614. doi: 10.1016/S2213-2600(18)30135-8. Epub 2018 Jun 18.
6
The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.慢性过敏性肺炎患者的 MUC5B 启动子多态性和端粒长度：一项观察性队列对照研究。
Lancet Respir Med. 2017 Aug;5(8):639-647. doi: 10.1016/S2213-2600(17)30216-3. Epub 2017 Jun 22.
7
Telomere length in patients with pulmonary fibrosis associated with chronic lung allograft dysfunction and post-lung transplantation survival.肺纤维化合并慢性肺移植功能障碍及肺移植后生存患者的端粒长度。
J Heart Lung Transplant. 2017 Aug;36(8):845-853. doi: 10.1016/j.healun.2017.02.005. Epub 2017 Feb 4.
8
Genetic Evaluation and Testing of Patients and Families with Idiopathic Pulmonary Fibrosis.特发性肺纤维化患者及其家系的基因评估与检测
Am J Respir Crit Care Med. 2017 Jun 1;195(11):1423-1428. doi: 10.1164/rccm.201609-1820PP.
9
Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive.端粒相关的肺纤维化在诊断上具有异质性，但均呈进行性发展。
Eur Respir J. 2016 Dec;48(6):1710-1720. doi: 10.1183/13993003.00308-2016. Epub 2016 Aug 18.
10
Telomere dysfunction causes alveolar stem cell failure.端粒功能障碍导致肺泡干细胞衰竭。
Proc Natl Acad Sci U S A. 2015 Apr 21;112(16):5099-104. doi: 10.1073/pnas.1504780112. Epub 2015 Apr 3.
Zotero 插件